Series A round lead investors NordicNinja and Industrifonden to support Combinostics as they scale to US and Asia
Helsinki, Finland, November 21, 2019 – Finnish health tech pioneer Combinostics has announced the closure of a €3.9M series A funding round that will see the company scale its platform for early-stage Alzheimer’s diagnosis to the US and Asia. The round was jointly-led by Industrifonden and NordicNinja VC, with Combinostics representing NordicNinja’s fifth deep tech investment over the past 6 months.
For additional information
Our cNeuro platform combines imaging data with clinical data and provides an intuitive and holistic view of patient data that highlights important relationships early on and supports early diagnosis. Our users include radiology and neurology departments in the EU, US, Japan, and South Korea. For more information, visit combinostics.com
The fund is backed by the Japan Bank for International Cooperation, Honda, Panasonic, and Omron. The fund and its “Ninja Intelligence” bring contacts, knowledge, and financial resources for companies ready to engage with Asian markets. For more information, visit www.nordicninja.vc
Industrifonden is a Nordic venture capital investor based in Stockholm. We invest in emerging science and technology ventures that have a meaningful impact on society. Our portfolio includes ventures like Amra, Adaptive Simulations, Crosser and NuvoAir. For more information, visit www.industrifonden.com.